GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
The emerging field of advanced therapy medicinal products (ATMP) holds promise of treating a variety of diseases. Adipose-derived stromal cells (ASCs) are currently being marketed or tested as cell-based therapies in numerous clinical trials. To ensure safety and efficacy of treatments, high-quality...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2022/4664917 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850212880710893568 |
|---|---|
| author | Mandana Haack-Sørensen Ellen Mønsted Johansen Lisbeth Drozd Højgaard Jens Kastrup Annette Ekblond |
| author_facet | Mandana Haack-Sørensen Ellen Mønsted Johansen Lisbeth Drozd Højgaard Jens Kastrup Annette Ekblond |
| author_sort | Mandana Haack-Sørensen |
| collection | DOAJ |
| description | The emerging field of advanced therapy medicinal products (ATMP) holds promise of treating a variety of diseases. Adipose-derived stromal cells (ASCs) are currently being marketed or tested as cell-based therapies in numerous clinical trials. To ensure safety and efficacy of treatments, high-quality products must be manufactured. A good manufacturing practice (GMP) compliant and consistent manufacturing process including validated quality control methods is critical. Product design and formulation are equally important to ensure clinical feasibility. Here, we present a GMP-compliant, xeno-free, and semiautomated manufacturing process and quality controls, used for large-scale production of a cryopreserved off-the-shelf ASC product and tested in several phase I and II allogeneic clinical applications. |
| format | Article |
| id | doaj-art-9034ed2008c348148803be4bbde7f2df |
| institution | OA Journals |
| issn | 1687-9678 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-9034ed2008c348148803be4bbde7f2df2025-08-20T02:09:14ZengWileyStem Cells International1687-96782022-01-01202210.1155/2022/4664917GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical UseMandana Haack-Sørensen0Ellen Mønsted Johansen1Lisbeth Drozd Højgaard2Jens Kastrup3Annette Ekblond4Cardiology Stem Cell CentreCardiology Stem Cell CentreCardiology Stem Cell CentreCardiology Stem Cell CentreCardiology Stem Cell CentreThe emerging field of advanced therapy medicinal products (ATMP) holds promise of treating a variety of diseases. Adipose-derived stromal cells (ASCs) are currently being marketed or tested as cell-based therapies in numerous clinical trials. To ensure safety and efficacy of treatments, high-quality products must be manufactured. A good manufacturing practice (GMP) compliant and consistent manufacturing process including validated quality control methods is critical. Product design and formulation are equally important to ensure clinical feasibility. Here, we present a GMP-compliant, xeno-free, and semiautomated manufacturing process and quality controls, used for large-scale production of a cryopreserved off-the-shelf ASC product and tested in several phase I and II allogeneic clinical applications.http://dx.doi.org/10.1155/2022/4664917 |
| spellingShingle | Mandana Haack-Sørensen Ellen Mønsted Johansen Lisbeth Drozd Højgaard Jens Kastrup Annette Ekblond GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use Stem Cells International |
| title | GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use |
| title_full | GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use |
| title_fullStr | GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use |
| title_full_unstemmed | GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use |
| title_short | GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use |
| title_sort | gmp compliant production of a cryopreserved adipose derived stromal cell product for feasible and allogeneic clinical use |
| url | http://dx.doi.org/10.1155/2022/4664917 |
| work_keys_str_mv | AT mandanahaacksørensen gmpcompliantproductionofacryopreservedadiposederivedstromalcellproductforfeasibleandallogeneicclinicaluse AT ellenmønstedjohansen gmpcompliantproductionofacryopreservedadiposederivedstromalcellproductforfeasibleandallogeneicclinicaluse AT lisbethdrozdhøjgaard gmpcompliantproductionofacryopreservedadiposederivedstromalcellproductforfeasibleandallogeneicclinicaluse AT jenskastrup gmpcompliantproductionofacryopreservedadiposederivedstromalcellproductforfeasibleandallogeneicclinicaluse AT annetteekblond gmpcompliantproductionofacryopreservedadiposederivedstromalcellproductforfeasibleandallogeneicclinicaluse |